Choi BD - Search Results

1

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.

Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV. Choi BD, et al. N Engl J Med. 2024 Apr 11;390(14):1290-1298. doi: 10.1056/NEJMoa2314390. Epub 2024 Mar 13. N Engl J Med. 2024. PMID: 38477966

2

IDH mutational status and the immune system in gliomas: a tale of two tumors?

Choi BD, Curry WT. Choi BD, et al. Transl Cancer Res. 2017 Oct;6(Suppl 7):S1253-S1256. doi: 10.21037/tcr.2017.09.37. Epub 2017 Sep 18. Transl Cancer Res. 2017. PMID: 29104858 Free PMC article. No abstract available.

3

Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma.

Choi BD, O'Rourke DM, Maus MV. Choi BD, et al. J Target Ther Cancer. 2017 Aug;6(4):22-25. J Target Ther Cancer. 2017. PMID: 29167820 Free PMC article.

4

Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.

Choi BD, Curry WT, Carter BS, Maus MV. Choi BD, et al. Neurosurg Focus. 2018 Jun;44(6):E13. doi: 10.3171/2018.2.FOCUS17788. Neurosurg Focus. 2018. PMID: 29852773 Review.

5

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.

Choi BD, Maus MV, June CH, Sampson JH. Choi BD, et al. Clin Cancer Res. 2019 Apr 1;25(7):2042-2048. doi: 10.1158/1078-0432.CCR-18-1625. Epub 2018 Nov 16. Clin Cancer Res. 2019. PMID: 30446589 Free PMC article. Review.

6

Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.

Boroughs AC, Larson RC, Choi BD, Bouffard AA, Riley LS, Schiferle E, Kulkarni AS, Cetrulo CL, Ting D, Blazar BR, Demehri S, Maus MV. Boroughs AC, et al. Among authors: choi bd. JCI Insight. 2019 Mar 14;5(8):e126194. doi: 10.1172/jci.insight.126194. JCI Insight. 2019. PMID: 30869654 Free PMC article.

7

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.

Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT. Choi BD, et al. J Neurosurg. 2019 Mar 29;132(4):1017-1023. doi: 10.3171/2018.12.JNS182700. J Neurosurg. 2019. PMID: 30925466

8

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas.

Richardson LG, Choi BD, Curry WT. Richardson LG, et al. Among authors: choi bd. Transl Cancer Res. 2019 Mar;8(Suppl 2):S167-S170. doi: 10.21037/tcr.2019.01.08. Transl Cancer Res. 2019. PMID: 30956952 Free PMC article. No abstract available.

9

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus MV. Frigault MJ, et al. Among authors: choi bd. Blood. 2019 Sep 12;134(11):860-866. doi: 10.1182/blood.2019001694. Epub 2019 Jul 18. Blood. 2019. PMID: 31320380 Free PMC article.

10

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity.

Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarfò I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus MV. Choi BD, et al. Nat Biotechnol. 2019 Sep;37(9):1049-1058. doi: 10.1038/s41587-019-0192-1. Epub 2019 Jul 22. Nat Biotechnol. 2019. PMID: 31332324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page